Oramed Pharmaceuticals Inc.
Develops oral drug delivery systems to turn injectable drugs, like insulin, into oral therapies.
ORMP | TA
Overview
Corporate Details
- ISIN(s):
- US68403P2039
- LEI:
- Country:
- Israel
- Address:
- 20 Mamilla Avenue, 9414904 Jerusalem
- Website:
- https://www.oramed.com
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Oramed Pharmaceuticals Inc. is a clinical-stage pharmaceutical company specializing in the development of oral drug delivery systems. Established in 2006, the company leverages its proprietary platform technology to transform injectable drugs into oral therapies, aiming to enhance patient comfort, compliance, and safety. Its flagship product is an oral insulin capsule for the treatment of type 2 diabetes, which has undergone extensive clinical development. Oramed's primary focus is on providing non-invasive alternatives to injected medications, particularly for chronic conditions like diabetes.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-22 09:42 |
Post-Annual General Meeting Information
Other Report or Announcement
|
English | 118.7 KB | ||
| 2025-08-22 09:42 |
Foreign Filer Report
Other Report or Announcement
|
English | 36.4 KB | ||
| 2025-08-22 09:41 |
Registration Form
Other Report or Announcement
|
English | 181.3 KB | ||
| 2025-08-22 09:41 |
Foreign Filer Report
Other Report or Announcement
|
English | 36.4 KB | ||
| 2025-08-17 15:18 |
Foreign Filer Report
FORM 10-Q- FINANCIAL STATEMENTS AS OF JUNE 30, 2025
|
English | 36.4 KB | ||
| 2025-08-17 15:16 |
Major Shareholding Notification
Form 13G
|
English | 93.7 KB | ||
| 2025-08-17 15:16 |
Foreign Filer Report
Form 13G
|
English | 36.4 KB | ||
| 2025-07-23 17:53 |
Delisting Announcement
Option Agreement for the Repurchase of Warrants
|
English | 316.7 KB | ||
| 2025-07-23 17:53 |
Foreign Filer Report
Option Agreement for the Repurchase of Warrants
|
English | 36.4 KB | ||
| 2025-07-18 14:52 |
Proxy Solicitation & Information Statement
Other Report or Announcement
|
English | 1.4 MB | ||
| 2025-07-18 14:52 |
Proxy Solicitation & Information Statement
Other Report or Announcement
|
English | 36.4 KB | ||
| 2025-07-18 14:51 |
Registration Form
Other Report or Announcement
|
English | 448.1 KB | ||
| 2025-07-18 14:51 |
Registration Form
Other Report or Announcement
|
English | 36.4 KB | ||
| 2025-07-18 14:50 |
Annual / Quarterly Financial Statement
Other Report or Announcement
|
English | 359.9 KB | ||
| 2025-07-18 14:50 |
Foreign Filer Report
Other Report or Announcement
|
English | 36.4 KB |
Automate Your Workflow. Get a real-time feed of all Oramed Pharmaceuticals Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Oramed Pharmaceuticals Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Oramed Pharmaceuticals Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
